v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows - operating activities    
Net income $ 985 $ 1,088
Adjustments to reconcile Net income to Cash from (used for) operating activities:    
Depreciation of property, plant, and equipment 154 138
Amortization of intangible assets 159 146
Gain on remeasurement of Nihon Medi-Physics equity method investment 0 (97)
Net periodic postretirement benefit plan (income) expense (93) (138)
Postretirement plan contributions (171) (182)
Share-based compensation 80 56
Provision for income taxes 213 216
Cash paid during the year for income taxes (231) (270)
Changes in operating assets and liabilities, excluding the effects of acquisitions:    
Receivables 62 185
Inventories (310) (188)
Contract and other deferred assets (132) (48)
Accounts payable 21 (113)
Contract liabilities 83 (23)
Current compensation and benefits (231) (207)
All other operating activities – net (130) (218)
Cash from (used for) operating activities 458 344
Cash flows – investing activities    
Additions to property, plant and equipment and internal-use software (278) (238)
Purchases of businesses, net of cash acquired (2,293) (279)
Purchases of investments (19) (28)
All other investing activities – net (24) (84)
Cash from (used for) investing activities (2,615) (630)
Cash flows – financing activities    
Net increase (decrease) in borrowings (maturities of 90 days or less) (1) 1
Newly issued debt, net of debt issuance costs (maturities longer than 90 days) 1,152 1,493
Repayments and other reductions (maturities longer than 90 days) (1,012) (261)
Dividends paid to stockholders (32) (32)
Repurchase of common stock (300) (100)
Proceeds from stock issued under employee benefit plans 10 21
Taxes paid related to net share settlement of equity awards (21) (33)
All other financing activities – net (12) (15)
Cash from (used for) financing activities (215) 1,075
Effect of foreign currency rate changes on cash, cash equivalents, and restricted cash (35) 84
Increase (decrease) in cash, cash equivalents, and restricted cash (2,407) 873
Cash, cash equivalents, and restricted cash at beginning of year 4,515 2,893
Cash, cash equivalents, and restricted cash at end of period 2,108 3,766
Supplemental disclosure of cash flows information    
Cash paid during the year for interest (280) (260)
Non-cash investing activities    
Acquired but unpaid property, plant, and equipment $ 102 $ 90